4.3 Review

N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease

Related references

Note: Only part of the references are listed.
Article Physiology

Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides

Kelly S. Schweitzer et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)

Article Multidisciplinary Sciences

THE REDUCTION IN VITRO IN VISCOSITY OF MUCOPROTEIN SOLUTIONS BY A NEW MUCOLYTIC AGENT, N-ACETYL-L-CYSTEINE

A. L. Sheffner

Annals of the New York Academy of Sciences (2010)

Article Biochemistry & Molecular Biology

The tyrosine phosphatase, SHP-1, is involved in bronchial mucin production during oxidative stress

Min Kyoung Jang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Article Respiratory System

Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways

C. A. Hewson et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Article Critical Care Medicine

Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation

HS Deshmukh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Article Physiology

Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1β in human bronchial epithelia

T Gray et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)

Article Respiratory System

Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats

M Mata et al.

EUROPEAN RESPIRATORY JOURNAL (2003)

Article Critical Care Medicine

Airways inflammation and COPD - Epithelial-neutrophil interactions

CA Pettersen et al.

CHEST (2002)

Review Biochemistry & Molecular Biology

Regulation of redox glutathione levels and gene transcription in lung inflammation: Therapeutic approaches

I Rahman et al.

FREE RADICAL BIOLOGY AND MEDICINE (2000)